Summary. In the ruminant placenta 15\p=n-\20%of the trophectodermal epithelium consists of granulated binucleate cells (BNC) Previous reports of degeneration of BNC structure plus a decrease in their number (with bromocriptine) or an increase in migration frequency (after adrenalectomy or stalk section) have not been confirmed by this study. The BNC migration delivers the oPL-containing BNC granules close to the maternal circulation but the variation in migration seems only loosely correlated with the reported maternal oPL concentrations.
Introduction
Binucleate cells with characteristic granules are found in all ruminant placentae which have been examined histologically so far (Amoroso, 1952; Wooding, 1982) . They occur in high frequency in the fetal trophectoderm throughout gestation, consistently forming between 15 and 20% of the cells in that layer but abruptly decreasing shortly before parturition (Wooding, 1983) . They first appear just after blastocyst elongation and seem to play a crucial role in ruminant implantation (Wathes & Wooding, 1980;  Wooding & Staples, 1981; Wooding, 1984) .
Binucleate cell development and fine structure are very similar in all ruminants so far studied.
There is also evidence which suggests that all share the capacity to migrate out of the trophecto¬ derm to fuse with maternal uterine epithelial cells or derivatives (Wooding, 1982) and thereby deliver their characteristic granules close to the maternal connective tissue for subsequent release by exocytosis. In the sheep these granules have been shown by immunoelectron-microscopical techniques to contain ovine placental lactogen (Wooding, 1981) .
The control of the production and migration of binucleate cells may thus play a vital role in ruminant implantation and placental growth. It has been suggested that fetal pituitary stalk section (Steven et al, 1978) , fetal adrenalectomy (Barnes, Comline, Silver & Steven, 1976) or bromocrip¬ tine administration (Lowe et al, 1979a) affect the growth and/or mobility of these cells. This paper reports the first quantitative study of binucleate cell distribution after various treatments to the pregnant ewe or fetus, the object being to identify the factors controlling this cell population. (Wooding, 1983) . Briefly, the animals were killed with an overdose of pentobarbitone sodium (or a placentome was removed during surgery), the placentome(s) were perfused with a glutaraldehyde fixative with or without subsequent osmium, and processed via alcohol and propyleneoxide to araldite. Sections were stained with phosphotungstic acid (non-osmicated tissue) or with uranyl acetate and lead citrate (osmicated tissue) and the counting was done on the electron microscope. For estimation of the proportion of cell types in the trophectodermal epithelium only cells containing a nuclear profile were counted. When a binucleate cell had two nuclear profiles only one was added to the total. All nuclei along one strip of trophectodermal epithelium were counted until the number in the uninucleate category reached 100. This constitutes one 'observation' (see tables). The count was then repeated at random non-overlapping positions on sections including the entire depth of the placentomal villi. Binucleate cells which formed part of the apical trophecto¬ dermal tight junction were classified as migrating. This produces a migration percentage which does not represent a rate of migration unless it is assumed that the speed of the movement of the binucleate cell through the tight junction is the same at all stages of pregnancy. The autoradiographie evidence (Wooding, Flint, Heap & Hobbs, 1981) (Ricketts & Flint, 1980b) . Carunclectomy performed during anoestrus removed on average 60% of the caruncles in the year before that in which pregnancy was established (Ricketts & Flint, 1980a (Steven et al, 1978) , adrenalectomy (Barnes et al, 1976) or infusion of bromocriptine (Lowe et al, 1979a, b) (1976) , Lowe et al. (1979a, b) and Steven et al. (1978) , and were used for counting. Pituitary stalk section was per¬ formed via the frontal bone with a silicone rubber block injected to maintain division of the stalk (Nathanielszera/., 1978) .
Epostane (WIN 32729: (2a,4a,5a,17ß) 4,5-epoxy-17 hydroxy-4,17 dimethyl, 3-oxo-andiostane-2-carbonitrile) is a steroid synthesis inhibitor (Taylor, Jenkin, Robinson & Thorburn, 1982a) and was a generous gift from Dr W. E. Jones, Sterling Winthrop Ltd, Surbiton, Surrey. This was administered intramuscularly to the dam, unless otherwise specified, as were progesterone (Intervet, Cambridge) and bromocriptine (Sigma, London). Tetracosactrin (Synacthen) was from Ciba, Horsham U.K.
Results
The variation of placen tomai binucleate cell populations throughout normal pregnancy is shown in Table 2 , Nos 5 and 10), although normally the levels would be similar (Wooding, 1983) . Granules were present in the syncytium that were equivalent morphologically to those in the binucleate cell, and there is good evidence (Wooding, 1982) (14) 5b (12) 6a (13) 6b (17) Epidermal growthfactor (EGF) (Group F, Table 3) Administration of EGF to fetuses has been reported to produce changes such as premature lung maturation and hair follicle development and an increased concentration of ovine placental lactogen in maternal blood (Thorburn et al, 1981) .
No effect of EGF infusion was detected on binucleate cell structure, numbers, or migration per¬ centage when compared with saline-infused controls or the 'normal' range ( Table 1 ). The frequency of binucleate cell-type granules in the syncytium was also unchanged. Fig. 2 shows a young BNC; Fig. 1 part of a mature granulated BNC). The normality of the ultrastructure in the uninucleate trophectoderm cells is illustrated in Fig. 3 , whereas some of the cells in the core of the fetal villi are degenerating (Fig. 2, arrowhead) , pc, Perfused maternal capillary .  Fig 1, 1900 ; Fig. 2, 6000; Fig. 3 (Wooding, 1983) by administration of tetracosactrin or cortisol to the fetus. This treatment also induces parturition within 3 or 4 days. The pre-partum fall and subsequent parturition were prevented by fetal hypophysectomy (3 out of 3) and restored by tetracosactrin infusion to a hypophysectomized fetus (3 out of 4). None of the other treatments (see below) had any consistent effect on the binucleate cell numbers, and no manipulation reproducibly changed the binucleate cell migration percentage.
The reduction in BNC numbers after tetracosactrin infusion was local since the saline or non-infused twin of the treated fetus did not show any corresponding decrease. The rate of binucleate cell production would therefore seem to be reduced by the hormonal or other chañes at parturition. However, there were exceptions and none of the evidence suggests that a decrease in binucleate numbers is obligatory in the initiation of parturition. In contrast to the fetal exper¬ iments, treatments to the ewes which produced abortion (ovariectomy at 21 days p.c.) or premature delivery (inhibition of progesterone synthesis with epostane at 134 days p.c.) did not affect the binucleate cell structure, numbers or migration. The production of binucleate cells therefore seems to be a fetal function rather than a response to a maternal stimulus. This suggestion is supported by the decrease in binucleate cell production in only the tetracosactrin-perfused fetus of twins and the similar decrease in the placenta of a twin that died 7 days before sampling. The placental trophectoderm of the dead fetus (No. 12b) was normal on all ultrastructural criteria (Figs 1-3 ) but binucleate cells were very rare.
Fetal pituitary stalk section (Steven et al, 1978) or adrenalectomy (Barnes et al, 1976) have been reported to increase the migration percentage. Counts made on material from the Steven et al (1978) and Barnes et al (1976) experiments indicated a significant increase in migration percentage of only 1 of the 2 stalk-sectioned fetuses and a decrease with adrenalectomy. The difference between the results may be due to the fact that the considerable normal migration level was not realized by these authors and that migrations do occasionally occur in groups (Wooding, 1983) . Systematic counting of an acceptably large statistical sample on sections where the migrations are highlighted (Wooding, 1980 (Wooding, , 1983 provides a much more reliable method of establishing the basic data than random observations. Bromocriptine administration to fetus or ewe (Lowe et al, 1979a) has been reported to increase the binucleate cell migration percentages and cause degranulation and degeneration of the binucleate cells. We could neither reproduce nor confirm these results. We evaluated placental material from our own experimental animals (intramuscular injection) and from one of the reportedly most severely affected animals from the study of Lowe et al (1979a: No. 6R532, fetal infusion; in the present study No. 31). We could find no significant differences from our controls or from the normal range for the particular stage of pregnancy.
There have been three independent reports that only the binucleate cells and specifically their granules contain the protein hormone ovine placental lactogen (oPL), also known as ovine chorionic somatommamotrophin (oCS) (Martal, Djiane & Dubois, 1977; Watkins & Reddy 1980; Wooding, 1981) . There is one report of a more general chorionic distribution, excluding the binucleate cells (Carnegie, Chan, McCully, Robertson & Friesen, 1982) , but the light micrographs are lacking in resolution, difficult to interpret and unconvincing. Ovine placental lactogen is present during pregnancy only, in maternal and fetal circulations. It first appears in the conceptus just before implantation, rises to a peak value in the maternal circulation at 120-130 days p.c. and declines to a low figure at term Taylor et al, 1978; Chan, Robertson & Friesen, 1978) . A similar pattern has been reported for caprine placental lactogen (Hayden, Thomas, Smith & Forsyth, 1980 . This pattern correlates well with the numbers of binucleate cells present in the placenta. After fetal hypophysectomy the normal fall in the maternal placental lactogen concentration towards term does not occur, fetal death in utero causes a rapid decrease, and bromocriptine administration is without effect (Taylor et al, 1982a; Taylor, McQuillen, Jenkin, Robinson & Thorburn, 1982b; Taylor, Robinson, Jenkin & Thorburn, 1983a, b Furthermore, Thorburn et al. (1981) reported that maternal ovine placental lactogen concen¬ trations increased by up to 300% after an infusion of epidermal growth factor (EGF) to the fetus. Counts on cotyledonary material from animals infused at the same EGF level showed no change in the binucleate cell numbers or migration percentage. Although bromocriptine as used by Taylor et al (1983b) and Martal & Djiane (1978) in ewes had no effect on maternal or fetal serum concen¬ trations, Lowe et al (1979b) in sheep and Buttle, Cowie, Jones & Turvey (1979) in goats have claimed a decrease in ovine placental lactogen or total lactogenic activity in maternal serum after use of the drug. There appears to be a fundamental statistical error in the treatment of results by Lowe et al (1979b) ; using the same methods of calculation detailed in that paper we can find no significant differences between the stated (p. 775) ovine placental lactogen levels in bromocriptinetreated (470-1 ±97-2 ng/ml, mean + s.e., = 5) and control (395-2 + 68-9 n/ml, = 5) ewes. The further claim of a within-animal significant difference, with no figures given, must therefore be equally suspect. In the Buttle eral. (1979) experiment the goats were hemimastectomized and kept warm (18-22°C) which produced a prolactin concentration much higher than would be usual at this stage of pregnancy. With the much simpler experimental design used in the present paper (no hemimastectomy, normal temperatures, twice the bromocriptine dose but given i.m. for 4 days only) no changes were detected in total lactogenic activity or prolactin (which was within the nor¬ mal (low) range for this stage of pregnancy) or in binucleate cell numbers or migration percentages. The decrease in total lactogenic activity found in the Buttle et al (1979) study may therefore be a reflection of the unusual conditions or some unique property of the batch of bromocriptine used, rather than an expression of a primary action of bromocriptine on the binucleate cell population and its derivatives. This is corroborated by the study of Forsyth, Byatt & Iley (1985) using longterm bromocriptine treatment to goats; no changes in total lactogenic activity were detected. On balance the evidence seems against any consistent direct effect of bromocriptine on placental lactogen concentrations or binucleate cell behaviour.
However, Martal & Lacroix (1978) (Grandis & Handwerger, 1983) .
The hypothesis that the binucleate cells synthesize and store all the goat and sheep placental lactogen and that they all migrate to form the syncytium from which the granules are released to the maternal circulation fits well with much of the published work. However, we still know little about how binucleate cell production and migration are regulated and previous reports of changes induced by fetal stalk section, adrenalectomy or bromocriptine administration have not been con¬ firmed in this study. The basic facts concerning the distribution and behaviour of the binucleate cell population have now been clearly outlined. The results indicate that the fetus is directly involved in maintaining binucleate cell production, and that the hormonal changes before parturition block this process. Once produced it seems that the binucleate cell will mature and migrate whatever the conditions.
